Publicis Resolute launches in Asia PacificPublicis Resolute has expanded its operations with the launch of a new hub in the Asia-Pacific (APAC) region. Share XPublicis Resolute launches in Asia Pacifichttps://pharmaphorum.com/news/publicis-resolute-launches-in-asia-pacific/
AliveCor launches six-lead ECG smartphone device in UKAliveCor has announced the launch of its flagship KardiaMobile six-lead personal ECG smartphone device in the UK. The Share XAliveCor launches six-lead ECG smartphone device in UKhttps://pharmaphorum.com/news/alivecor-launches-six-lead-ecg-smartphone-device-in-uk/
Roche’s Xofluza limits spread of flu virus, says new studyRoche’s new influenza drug Xofluza can dramatically prevent the spread of the virus when used as a preventive Share XRoche’s Xofluza limits spread of flu virus, says new studyhttps://pharmaphorum.com/news/roches-xofluza-limits-spread-of-flu-virus-says-new-study/
Heart failure results could unlock key market for Farxiga – AZAstraZeneca doesn’t quite know why its diabetes drug Farxiga is also working in patients with heart failure – Share XHeart failure results could unlock key market for Farxiga – AZhttps://pharmaphorum.com/news/heart-failure-results-could-unlock-key-market-for-farxiga-az/
Despite trial miss, Novartis still believes in Entresto for HFpEFNovartis was expecting a lot from its PARAGON-HF trial of Entresto in heart failure with preserved ejection fraction Share XDespite trial miss, Novartis still believes in Entresto for HFpEFhttps://pharmaphorum.com/news/despite-trial-miss-novartis-still-believes-in-entresto-for-hfpef/
Novartis looks set to repurpose cancer drug in MS after trial winsNovartis has announced data supporting a cancer drug it acquired from GlaxoSmithKline and Genmab in a new use Share XNovartis looks set to repurpose cancer drug in MS after trial winshttps://pharmaphorum.com/news/novartis-looks-set-to-repurpose-cancer-drug-in-ms-after-trial-wins/
Mylan up on OK for generic of Lilly’s $2bn cancer drug AlimtaShares in Mylan have risen after the FDA gave a tentative approval to its generic version of Eli Share XMylan up on OK for generic of Lilly’s $2bn cancer drug Alimtahttps://pharmaphorum.com/news/mylan-up-on-ok-for-generic-of-lillys-2bn-cancer-drug-alimta/
Allocate and Patchwork partner to increase NHS workforce efficiencyTwo firms specialising in digital staffing rosters in the NHS have announced a partnership that will allow their Share XAllocate and Patchwork partner to increase NHS workforce efficiencyhttps://pharmaphorum.com/news/allocate-and-patchwork-partner-to-increase-nhs-workforce-efficiency/
Immunicum shares fall despite “fantastic” kidney cancer dataShares in Swedish biotech Immunicum dipped sharply after it reported phase 2 results with its lead dendritic cell Share XImmunicum shares fall despite “fantastic” kidney cancer datahttps://pharmaphorum.com/news/immunicum-shares-fall-despite-fantastic-kidney-cancer-data/
